PHILADELPHIA — Patients with chronic spontaneous urticaria had positive outcomes weeks after barzolvolimab, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results